Cargando…

Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review

Radiation therapy (RT) is a curative treatment option for localized prostate cancer. Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule (IDN) is an emerging treatment option that involves the prophylactic irradiation of the whole prostate while increasing RT doses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feutren, Thomas, Herrera, Fernanda G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104294/ https://www.ncbi.nlm.nih.gov/pubmed/30140656 http://dx.doi.org/10.1016/j.prnil.2018.03.005

Ejemplares similares

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
por: Abe, Eisuke, et al.
Publicado: (2010)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study
por: Ong, Ashley Li Kuan, et al.
Publicado: (2023)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)

Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI
por: Lee, Joon, et al.
Publicado: (2019)

Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using (68)Ga- PSMA PET/CT
por: Bamneshin, Khadijeh, et al.
Publicado: (2022)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study
por: Cloitre, Minna, et al.
Publicado: (2023)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study
por: Rischke, Hans Christian, et al.
Publicado: (2013)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2018)

The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Determination of Intraprostatic and Intratesticular Androgens
por: Šimková, Markéta, et al.
Publicado: (2021)

Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions
por: Luminais, Christopher K., et al.
Publicado: (2022)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Intraprostatic ozone therapy: A minimally invasive approach in benign prostatic hyperplasia
por: Hussain, Shabbir, et al.
Publicado: (2017)

Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer – a retrospective analysis of dose-escalated patients
por: Link, Carola, et al.
Publicado: (2019)

Intraprostatic Hydatid Cyst: An Unusual Presentation
por: Nouira, Yassine, et al.
Publicado: (2006)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

Intraprostatic Injection of Alcohol Gel for the Treatment of Benign Prostatic Hyperplasia: Preliminary Clinical Results
por: Larson, Benjamin T., et al.
Publicado: (2006)

Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
por: Cozzi, Salvatore, et al.
Publicado: (2023)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
por: Hou, Wei-Hsien, et al.
Publicado: (2017)

The Role of Intraprostatic Inflammation in the Acute Urinary Retention
por: Asgari, Seyed Alaeddin, et al.
Publicado: (2011)

Quantification of the margin required for treating intraprostatic lesions
por: Studenski, Matthew T., et al.
Publicado: (2016)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [(18)F]DCFPyL-PET: comparison to [(18)F]fluorocholine-PET
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer
por: Dankulchai, Pittaya, et al.
Publicado: (2022)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
por: Hsu, Yu-Chao, et al.
Publicado: (2016)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

MRI-guided, transrectal, intraprostatic steam application as potential focal therapeutic modality for prostatic diseases in a large animal translational model: A feasibility follow-up study
por: Wang-Leandro, Adriano, et al.
Publicado: (2019)

Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence
por: Priester, Alan, et al.
Publicado: (2023)

Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
por: Thomas, Christopher, et al.
Publicado: (2022)

Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
por: Moreau, Juliette, et al.
Publicado: (2017)

Prospective Evaluation of Probabilistic Dose-escalated IMRT in Prostate Cancer
por: Wegener, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mves4pfsg1m13iul2hu8br7rh6